Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Immunodeficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00002263
What this trial is testing

A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine

Who this might be right for
HIV InfectionsCytopenias
Sandoz
Large-scale testing (Phase 3)Study completedNCT01905059
What this trial is testing

Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 265
Testing effectiveness (Phase 2)Study completedNCT04030598
What this trial is testing

Assess the Clinical Efficacy of Donidalorsen (Also Known as IONIS-PKK-LRx and ISIS 721744) in Participants With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Ionis Pharmaceuticals, Inc. 23
Large-scale testing (Phase 3)Study completedNCT00988039
What this trial is testing

Europe-Africa Research Network for Evaluation of Second-line Therapy

Who this might be right for
Human Immunodeficiency VirusHIV
Justine Boles 1,277
Large-scale testing (Phase 3)Study completedNCT01360762
What this trial is testing

Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study

Who this might be right for
Visceral LeishmaniosisHIV-infection/Aids
Institute of Tropical Medicine, Belgium 74
Early research (Phase 1)Looking for participantsNCT06513819
What this trial is testing

HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)

Who this might be right for
HivAlcohol DrinkingFall+1 more
Yale University 100
Testing effectiveness (Phase 2)Study completedNCT03991013
What this trial is testing

Tenofovir-lamivudine-dolutegravir Combination as Second-line ART: a Randomised Controlled Trial

Who this might be right for
HIV Infections
University of Cape Town 192
Not applicableActive Not RecruitingNCT05699785
What this trial is testing

Comparison of Inflammatory Markers and Incidence of Comorbidities in Patients on Antiretroviral Therapy With Second-generation Anti-integrase Drugs on Triple Versus Dual Therapy

Who this might be right for
Hiv
Centre Hospitalier Universitaire de Nice 500
Large-scale testing (Phase 3)Study completedNCT02817451
What this trial is testing

DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 53
Testing effectiveness (Phase 2)Study completedNCT00887120
What this trial is testing

Dose Reduction of Lopinavir in Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 24
Large-scale testing (Phase 3)Study completedNCT03730129
What this trial is testing

Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig

Who this might be right for
Secondary Immune Deficiency Disorder
Rochester General Hospital 20
Not applicableActive Not RecruitingNCT04354129
What this trial is testing

Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency.

Who this might be right for
Primary Immune Deficiency DisorderSecondary Immune Deficiency
University of Alberta 36
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Large-scale testing (Phase 3)Study completedNCT00000727
What this trial is testing

A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 322
Not applicableStudy completedNCT02303093
What this trial is testing

Non-Interventional Study on the Tolerability and Efficacy of IVIG

Who this might be right for
Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG
Octapharma 344
Not applicableLooking for participantsNCT01666080
What this trial is testing

Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

Who this might be right for
Hematologic DisordersHemoglobinopathiesImmunodeficiencies
Masonic Cancer Center, University of Minnesota 30
Not applicableUnknownNCT03721146
What this trial is testing

ENCAPSID Study : ENCApsulated Bacterial Infection and Primary, Secondary ImmunoDeficiency

Who this might be right for
Immune Deficiency
University Hospital, Caen 50
Not applicableUnknownNCT04382508
What this trial is testing

Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.

Who this might be right for
Immune SuppressionImmune DeficiencyInfection+2 more
University Hospital Southampton NHS Foundation Trust 1,500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07662720
What this trial is testing

A Phase II Trial for MOR Antagonism With Axelopran to Enhance Immunotherapy in Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
Glycyx Therapeutics 18
Not applicableStudy completedNCT04172467
What this trial is testing

Quality Assurance of Secondary Immunodeficiencies (SID) in CLL/MM Patients

Who this might be right for
Secondary Immunodeficiencies (SID)
AIO-Studien-gGmbH 1,086
Next Page